The first independent peptide education resource built specifically for women. PubMed-cited. Evidence-rated. No clinic. No sales pitch.
"Peptide therapy content has been written for men, by men, about men — for years. Women metabolize differently, respond differently, and have entirely different therapeutic needs. We exist to close that gap with real science, not marketing."
FemPeptides was founded in 2026 with a simple observation: the peptide therapy space had zero independent educational resources built for women. Every guide, every dosing protocol, every "best peptides" article was written through a male biohacker lens — ignoring PCOS, perimenopause, menopause, postpartum recovery, fertility, and the dozens of conditions that disproportionately affect women.
We're not a clinic. We don't sell peptides. We don't accept payment for favorable coverage. Our revenue comes from clearly disclosed affiliate partnerships with vendors we've independently vetted — and our editorial process is completely separate from our business relationships.
Every claim on this site links to its source — PubMed, published clinical trials, or peer-reviewed research. If the evidence doesn't exist, we say so.
No vendor, clinic, or advertiser has editorial input. Our content team and affiliate partnerships operate with a strict separation of church and state.
When studies include female participants, we highlight women-specific outcomes. When they don't, we flag it — because "no data in women" is important information.
We track FDA classification, PCAC reviews, and legal status changes in real time. We don't frame investigational compounds as proven treatments.
Every peptide profile on FemPeptides includes an evidence strength rating. Here's how we assign them:
| Rating | What It Means | Criteria |
|---|---|---|
| Strong Clinical Evidence | Multiple RCTs in humans, FDA-approved indication, or extensive Phase III data | |
| Good Clinical Evidence | At least one RCT or multiple well-designed human studies with consistent findings | |
| Moderate Evidence | Pilot human studies, observational data, or strong preclinical evidence with limited human data | |
| Limited Evidence | Primarily animal models with preliminary human case reports or small open-label studies | |
| Emerging Research | Animal studies only, theoretical mechanisms, or very early-stage investigation |
FemPeptides is maintained by a team of researchers, writers, and medical professionals committed to accurate, accessible health education for women.
Our writers hold backgrounds in biochemistry, health journalism, and clinical research. Every article undergoes fact-checking against primary sources before publication.
All peptide profiles and clinical content are reviewed by licensed healthcare providers with experience in peptide therapy, endocrinology, or integrative medicine.
We're currently expanding our medical review board. If you're a licensed healthcare provider with peptide therapy experience and interest in women's health education, we'd love to hear from you.
We cite primary sources (PubMed, clinical trial registries, FDA documents). We disclose affiliate relationships on every page. We flag when evidence comes from animal models only. We note when studies lack female participants. We update content when regulatory status changes. We rate evidence strength transparently.
We never fabricate testimonials or reviews. We never present investigational compounds as proven treatments. We never provide dosing instructions or direct medical advice. We never accept payment for editorial placement. We never recommend peptides for off-label uses without clearly stating the regulatory context.
Take our 60-second quiz and get matched with peptides based on your goals, life stage, and preferences.
Find Your Peptide →